Skip to search boxSkip to navigationSkip to main content

Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder

  • Karen A. Nolan(corresponding author)
    ,
  • Jan Volavka
    ,
  • Pal Czobor
    ,
  • Brian Sheitman
    ,
  • Jean Pierre Lindenmayer
    ,
  • Leslie L. Citrome
*Corresponding author for this work
  • New York State Office of Mental Health
    ,
  • New York University
    ,
  • University of North Carolina at Chapel Hill
    ,
  • Duke University
Scholary Output:
Contribution to journal
Article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Positive psychotic symptoms, such as threat/"control-override" delusions or command hallucinations, have been related to aggression in patients with schizophrenia. However, retrospective data collection has hampered evaluation of the direct influence of psychopathology on aggressive behavior. In this study, we monitored aggressive behavior and psychopathology prospectively and in close temporal proximity in 157 treatment-resistant inpatients diagnosed with chronic schizophrenia or schizoaffective disorder participating in a 14-week double-blind clinical trial. Aggressive behavior was rated with the overt aggression scale (OAS). Psychopathology was assessed using the positive and negative syndrome scale (PANSS). At baseline, subjects who would be aggressive during the study had higher scores on only two PANSS items: hostility and poor impulse control. During the study PANSS positive subscale scores were significantly higher in aggressive subjects. Total PANSS scores were higher within 3 days of an aggressive incident, as were positive and general psychopathology subscale scores. However, in a smaller subsample for whom PANSS ratings were available within 3 days before aggressive incidents, only scores on the PANSS positive subscale were significantly higher. These findings in chronic, treatment resistant inpatients support the view that positive symptoms may lead to aggression.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 109-115 (7 pages)

Journal (Volume, Issue Number)

Journal of Psychiatric Research (Volume 39, Issue 1)

Publication milestones

  • Published - 01/2005

Publication status

Published - 01/2005

ISSN

0022-3956

Publication IDs

  • Scopus: 7044222806
  • PubMed: 15504429

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.13
Fractional count
7
Fractional count
0.88
Fractional count
1
Fractional count
1
SciVal
citations
62
SciVal
FWCI
1.22
SciVal
Author count
8
SciVal
Paper percentile
90
SciVal
Top percentile
10

PlumX, opens in new tab

Citation count
78
Captures
71

Funding Details

NIMH Grant (R10 MH53550) provided the principal support for this project. Additional support was provided by the UNC-Mental Health and Neuroscience Clinical Research Center (MH MH33127) and the Foundation of Hope, Raleigh North Carolina. We thank Janssen Pharmaceutica Research Foundation, Eli Lilly and Company, Novartis Pharmaceuticals Corporation, and Merck and Co., Inc. for their generous gifts of medications. Eli Lilly and Company contributed supplemental funding that covered approximately 18% of the total cost of the study. However, overall experimental design, data acquisition, statistical analyses, and interpretation of the results were implemented without any input from any of the pharmaceutical companies. Linda Kline, RN, MS, CS was the chief coordinator of the entire project.
FundersFunding numbers
UNC-Mental Health and Neuroscience Clinical Research Center
MH MH33127
NIMH
R10MH053550